AR070618A1 - Derivados de indeno[5,6-d]tiazol como ligandosde receptores d2-078 - Google Patents
Derivados de indeno[5,6-d]tiazol como ligandosde receptores d2-078Info
- Publication number
- AR070618A1 AR070618A1 ARP090100601A ARP090100601A AR070618A1 AR 070618 A1 AR070618 A1 AR 070618A1 AR P090100601 A ARP090100601 A AR P090100601A AR P090100601 A ARP090100601 A AR P090100601A AR 070618 A1 AR070618 A1 AR 070618A1
- Authority
- AR
- Argentina
- Prior art keywords
- indenous
- tiazol
- derivatives
- receiving links
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Compuestos de formula (1) (R)-N*6*-etil-6,7-dihidro-5H-indeno[5,6-d]tiazol-2,6-diamina. Esta también se refiere a métodos para sintetizar, métodos para utilizar y a composiciones farmacéuticas que comprenden el compuesto de formula (1) y sus sales.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3033208P | 2008-02-21 | 2008-02-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR070618A1 true AR070618A1 (es) | 2010-04-21 |
Family
ID=40985770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090100601A AR070618A1 (es) | 2008-02-21 | 2009-02-20 | Derivados de indeno[5,6-d]tiazol como ligandosde receptores d2-078 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20090215841A1 (es) |
| EP (1) | EP2254876A4 (es) |
| JP (1) | JP2011512407A (es) |
| KR (1) | KR20100122487A (es) |
| CN (1) | CN101952266A (es) |
| AR (1) | AR070618A1 (es) |
| AU (1) | AU2009215920A1 (es) |
| BR (1) | BRPI0907158A2 (es) |
| CA (1) | CA2716215A1 (es) |
| CL (1) | CL2009000392A1 (es) |
| CO (1) | CO6300849A2 (es) |
| CR (1) | CR11639A (es) |
| DO (1) | DOP2010000257A (es) |
| EA (1) | EA201001095A1 (es) |
| EC (1) | ECSP10010412A (es) |
| IL (1) | IL206817A0 (es) |
| MX (1) | MX2010008923A (es) |
| NI (1) | NI201000141A (es) |
| PE (1) | PE20091566A1 (es) |
| SA (1) | SA109300120B1 (es) |
| TW (1) | TW200940516A (es) |
| UY (1) | UY31668A1 (es) |
| WO (1) | WO2009105026A1 (es) |
| ZA (1) | ZA201004800B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017219808A1 (zh) * | 2016-06-21 | 2017-12-28 | 浙江柏拉阿图医药科技有限公司 | 丙型肝炎病毒抑制剂及应用 |
| CN109134600B (zh) * | 2017-06-19 | 2021-07-20 | 杭州国谋生物科技有限公司 | 作为丙型肝炎抑制剂的烷基及杂环化合物及其在药物中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9802360D0 (sv) * | 1998-07-01 | 1998-07-01 | Wikstroem Hakan Vilhelm | New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins ((basic)-N-substituted and (basic)-N,N-disubstituted derivatives of 2,6-diamino-thiazolo(4,5-f)indan and 2,7-di-amino-thiazolo(4,5-g)tetralin |
| WO2005084205A2 (en) * | 2004-02-27 | 2005-09-15 | Teva Pharmaceutical Industries, Ltd. | Diamino thiazoloindan derivatives and their use |
-
2009
- 2009-02-18 SA SA109300120A patent/SA109300120B1/ar unknown
- 2009-02-19 US US12/388,548 patent/US20090215841A1/en not_active Abandoned
- 2009-02-20 WO PCT/SE2009/050188 patent/WO2009105026A1/en active Application Filing
- 2009-02-20 EA EA201001095A patent/EA201001095A1/ru unknown
- 2009-02-20 BR BRPI0907158-0A patent/BRPI0907158A2/pt not_active IP Right Cessation
- 2009-02-20 MX MX2010008923A patent/MX2010008923A/es not_active Application Discontinuation
- 2009-02-20 KR KR1020107018569A patent/KR20100122487A/ko not_active Application Discontinuation
- 2009-02-20 EP EP09711581A patent/EP2254876A4/en not_active Withdrawn
- 2009-02-20 AU AU2009215920A patent/AU2009215920A1/en not_active Abandoned
- 2009-02-20 JP JP2010547592A patent/JP2011512407A/ja active Pending
- 2009-02-20 CL CL2009000392A patent/CL2009000392A1/es unknown
- 2009-02-20 CN CN2009801061103A patent/CN101952266A/zh active Pending
- 2009-02-20 UY UY031668A patent/UY31668A1/es not_active Application Discontinuation
- 2009-02-20 TW TW098105543A patent/TW200940516A/zh unknown
- 2009-02-20 CA CA2716215A patent/CA2716215A1/en not_active Abandoned
- 2009-02-20 AR ARP090100601A patent/AR070618A1/es not_active Application Discontinuation
- 2009-02-20 PE PE2009000253A patent/PE20091566A1/es not_active Application Discontinuation
-
2010
- 2010-07-05 IL IL206817A patent/IL206817A0/en unknown
- 2010-07-07 ZA ZA2010/04800A patent/ZA201004800B/en unknown
- 2010-08-20 CR CR11639A patent/CR11639A/es not_active Application Discontinuation
- 2010-08-20 DO DO2010000257A patent/DOP2010000257A/es unknown
- 2010-08-20 NI NI201000141A patent/NI201000141A/es unknown
- 2010-08-20 EC EC2010010412A patent/ECSP10010412A/es unknown
- 2010-08-26 CO CO10105401A patent/CO6300849A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20090215841A1 (en) | 2009-08-27 |
| EA201001095A1 (ru) | 2011-04-29 |
| CL2009000392A1 (es) | 2010-09-24 |
| EP2254876A1 (en) | 2010-12-01 |
| ZA201004800B (en) | 2012-06-27 |
| MX2010008923A (es) | 2010-09-07 |
| BRPI0907158A2 (pt) | 2015-07-07 |
| TW200940516A (en) | 2009-10-01 |
| IL206817A0 (en) | 2010-12-30 |
| JP2011512407A (ja) | 2011-04-21 |
| KR20100122487A (ko) | 2010-11-22 |
| PE20091566A1 (es) | 2009-11-06 |
| CA2716215A1 (en) | 2009-08-27 |
| CN101952266A (zh) | 2011-01-19 |
| DOP2010000257A (es) | 2010-10-31 |
| EP2254876A4 (en) | 2012-10-31 |
| NI201000141A (es) | 2011-03-24 |
| SA109300120B1 (ar) | 2011-10-08 |
| ECSP10010412A (es) | 2010-09-30 |
| AU2009215920A1 (en) | 2009-08-27 |
| CR11639A (es) | 2010-10-05 |
| UY31668A1 (es) | 2009-09-30 |
| CO6300849A2 (es) | 2011-07-21 |
| WO2009105026A1 (en) | 2009-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6321276A2 (es) | Derivados de tiazol usados como inhibidores de pi3- cinasa | |
| UY32096A (es) | Derivados de 2-carboxamida - cicloamino - urea especìficos, sus sales farmacèuticamente aceptables, composiciones contenièndolos, pro-farmacos de los mismos, procesos para su produciòn y aplicaciones | |
| GT200800242A (es) | Derivados biciclicos como inhibidores de cetp | |
| CU20110235A7 (es) | Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17 | |
| CO6321282A2 (es) | Derivados de piperidinilindol como inhibidores de aldosterona sintasa | |
| SV2010003472A (es) | Compuestos de pirazol | |
| CR11620A (es) | Derivados de Imadazo-[1,2,b]-Piridazina para el Tratamiento de Enfermedad Mediada por Cinosa de Tirosina C-Met | |
| UY29360A1 (es) | Nuevos derivados de pirazol, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones. | |
| ECSP10010654A (es) | Derivados de tienopiridonas como activadores de proteína quinasa activados por amp (ampk) | |
| GT200600117A (es) | Nuevos compuestos farmaceuticos | |
| UY32296A (es) | Nuevos compuestos | |
| AR062211A1 (es) | Derivados de 6-carboxi-normorfinano. composiciones farmaceuticas | |
| DOP2006000017A (es) | Pirazolopiridinas y sales de las mismas, una composición farmaceútica que comprende dichos compuestos, un método para prepararlos y su uso | |
| ECSP088700A (es) | Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1 | |
| ATE445593T1 (de) | Acetylenderivate | |
| ECSP099565A (es) | Compuesto de 2-amino pirimidina | |
| ECSP10010192A (es) | 5-[(3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino]-1h-quinolin-2-onas, un proceso para su producción y su uso como agentes antiinflamatorios | |
| UA106880C2 (uk) | Нові гербіциди | |
| EA200801366A1 (ru) | Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина | |
| CO6341625A2 (es) | Derivados de indol como agentes anticáncer | |
| NI201100035A (es) | Agentes antifúngicos. | |
| AR070618A1 (es) | Derivados de indeno[5,6-d]tiazol como ligandosde receptores d2-078 | |
| ECSP11011150A (es) | Derivados de arilciclopropilacetamida útiles como activadores de glucoquinasa | |
| UY30343A1 (es) | Derivados de 1,2,3,4-tetrahidro-quinolina como inhibidores de cetp | |
| UY29273A1 (es) | Nuevos derivados de hidantoina, composiciones que los contienen, procesos de preparación y aplicaciones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |